drug overdose; acetaminophen; hepatotoxicitysobredosis de droga; acetaminofén; enfermedad hepática inducida por drogas y medicamentos.

1. Spooner JD, Harvey JG. The history of paracetamol and usage of paracetamol. J Int Med Res 1976; 4 (supl 1):1-6.
2. Bertolini A, Ferrari A, Ottani A, Guerzoni S, Tacchi R, Leone S. Paracetamol: New vistas of an old drug. CNS Drug Rev. 2006;12(3-4):250-75.
3. Gilbertson RJ, Harris E, Pandey SK, Kelly P, Myers W. Paracetamol use, availability, and knowledge of toxicity among British and American adolescents. Arch Dis Child. 1996; 75(3):194-8.
4. Graham GG, Davies MJ, Day RO, Mohamudally A, Scott KF. The modern pharmacology of paracetamol: Therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings. Inflammopharmacology. 2013 Jun;21(3):201-32.
5. Ostapowicz G, Fontana RJ, Schiødt FV, Larson A, Davern TJ, Han SH, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med. 2002; 137(12):947-54.
6. Zyoud SH, Al-Jabi SW, Sweileh WM. Worldwide research productivity of paracetamol (acetaminophen) poisoning: A bibliometric analysis (2003-2012). Hum Exp Toxicol. 2015; 34(1):12-23.
7. Tong HY, Medrano N, Borobia AM, Martínez AM, Martín J, Ruiz JA, et al. V Hepatotoxicity induced by acute and chronic paracetamol overdose in adults. Where do we stand? Regul Toxicol Pharmacol. 2015; 72(2):370-8.
8. Altyar A, Kordi L, Skrepnek G. Clinical and economic characteristics of emergency department visits due to acetaminophen toxicity in the USA. BMJ Open. 2015;5(9):e007368.
9. Major JM, Zhou EH, Wong HL, Trinidad JP, Pham TM, Mehta H, et al. Trends in rates of acetaminophen-related adverse events in the United States. Pharmacoepidemiol Drug Saf. 2016;25(5):590-8.
10. Aguilera P, Garrido M, Lessard E, Swanson J, Mallon WK, Saldias F, et al. Medication Overdoses at a Public Emergency Department in Santiago, Chile. West J Emerg Med. 2016; 17(1):75-80.
11. Blieden M, Paramore LC, Shah D, Ben-Joseph R. A perspective on the epidemiology of acetaminophen exposure and toxicity in the United States. Expert Rev Clin Pharmacol. 2014;7(3):341-8.
12. Serper M, Wolf MS, Parikh NA, Tillman H, Lee WM, Ganger DR. Risk factors, clinical presentation, and outcomes in overdose with acetaminophen alone or with combination products: results from the acute liver failure study group. J Clin Gastroenterol. 2016;50(1):85-91.
13. Schmidt LE. Age and paracetamol self-poisoning. Gut. 2005;54(5):686-90.
14. Vogel J, Heard KJ, Carlson C, Lange C, Mitchell G. Dental pain as a risk factor for accidental acetaminophen overdose: a case-control study. Am J Emerg Med. 2011;29(9):1125-9.
15. Bunchorntavakul C, Reddy KR. Acetaminophen-related hepatotoxicity. Clin Liver Dis. 2013;17(4):587-607.
16. Gulmez SE, Larrey D, Pageaux GP, Bernuau J, Bissoli F, Horsmans Y, et al. Liver transplant associated with paracetamol overdose: results from Cseven-country SALT study. Br J Clin Pharmacol. 2015;80(3):599-606.
17. Bertolini A, Ferrari A, Ottani A, Guerzoni S, Tacchi R, Leone S. Paracetamol: New vistas of an old drug. CNS Drug Reviews 2006;12(3-4):250-75.
18. Jóźwiak-Bebenista M, Nowak JZ. Paracetamol: mechanism of action, applications and safety concern. Acta Pol Pharm. 2014;71(1):11-23.
19. Raffa RB, Pergolizzi JV Jr, Taylor R Jr, Decker JF, Patrick JT. Acetaminophen (paracetamol) oral absorption and clinical influences. Pain Pract. 2014;14(7):668-77.
20. Téllez AM. Aspectos toxicológicos del acetaminofén [internet]. [Citado 2017 abr 10] Disponible en: http://clinicalevidence.pbworks.com/w/file/fetch/78806546/Aspectos
21. Bateman DN. Changing the management of paracetamol poisoning. Clin Ther. 2015;37(9):2135-41.
22. Jaeschke H. Acetaminophen: Dose-dependent drug hepatotoxicity and acute liver failure in patients. Dig Dis. 2015;33(4):464-71.
23. Yuan L, Kaplowitz N. Mechanisms of drug-induced liver injury. Clin Liver Dis. 2013;17(4):507-18.
24. Lei XG, Zhu JH, McClung JP, Aregullin M, Roneker CA. Mice deficient in Cu,Zn-superoxide dismutase are resistant to acetaminophen toxicity. Biochem J. 2006;399(3):455-61.
25. Inupakutika MA, Sengupta S, Devireddy AR, Azad RK, Mittler R. The evolution of reactive oxygen species metabolism. J Exp Bot. 2016;67(21):5933-5943.
26. Mello T, Zanieri F, Ceni E, Galli A. Oxidative Stress in the Healthy and Wounded Hepatocyte: A Cellular Organelles Perspective. Oxid Med Cell Longev. 2016;2016:8327410.
27. Yang X, Greenhaw J, Ali A, Shi Q, Roberts DW, Hinson JA, et al. Changes in mouse liver protein glutathionylation after acetaminophen exposure. J Pharmacol Exp Ther. 2012;340(2):360-8.
28. Kheradpezhouh E, Ma L, Morphett A, Barritt GJ, Rychkov GY. TRPM2 channels mediate acetaminophen-induced liver damage. Proc Natl Acad Sci U S A. 2014;111(8):3176-81.
29. Rychkov GY, Barritt GJ. Expression and function of TRP channels in liver cells. Adv Exp Med Biol. 2011;704:667-86.
30. Jaeschke H, Bajt ML. Intracellular signaling mechanisms of acetaminophen-induced liver cell death. Toxicol Sci. 2006;89(1):31-41.
31. Jaeschke H, McGill MR, Ramachandran A. Oxidant stress, mitochondria, and cell death mechanisms in drug-induced liver injury: Lessons learned from acetaminophen hepatotoxicity. Drug Metab Rev. 2012;44(1):88-106.
32. Du K, Xie Y, McGill MR, Jaeschke H. Pathophysiological significance of c-jun N-terminal kinase in acetaminophen hepatotoxicity. Expert Opin Drug Metab Toxicol. 2015;11(11):1769-79.
33. Hu J, Ramshesh VK, McGill MR, Jaeschke H, Lemasters JJ. Low Dose Acetaminophen Induces Reversible Mitochondrial Dysfunction Associated with Transient c-Jun N-Terminal Kinase Activation in Mouse Liver. Toxicol Sci. 2016;150(1):204-15.
34. Liu FC, Lee HC, Liao CC, Li AH, Yu HP. Tropisetron protects against acetaminophen-induced liver injury via suppressing hepatic oxidative stress and modulating the activation of JNK/ERK MAPK pathways. Biomed Res Int. 2016;2016:1952947.
35. Du K, Xie Y, McGill MR, Jaeschke H. Pathophysiological significance of c-jun N-terminal kinase in acetaminophen hepatotoxicity. Expert Opin Drug Metab Toxicol. 2015;11(11):1769-79.
36. Hu J, Ramshesh VK, McGill MR, Jaeschke H, Lemasters JJ. Low dose acetaminophen induces reversible mitochondrial dysfunction associated with transient c-Jun N-terminal kinase activation in mouse liver. Toxicol Sci. 2016;150(1):204-15.
37. Mancipe LC, Fernández DC, Fernández DG. Intoxicación por acetaminofén. Rev Fac Med. 2010;18(2):221-7.
38. Janssen J, Singh-Saluja S. How much did you take?: Reviewing acetaminophen toxicity. Can Fam Physician. 2015 Apr;61(4):347-9.
39. Papazoglu C, Ang JR, Mandel M, Basak P, Jesmajian S. Acetaminophen overdose associated with double serum concentration peaks. J Community Hosp Intern Med Perspect. 2015;5(6):29589.
40. Hendrickson RG, McKeown NJ, West PL, Burke CR. Bactrian (“double hump”) acetaminophen pharmacokinetics: a case series and review of the literature. J Med Toxicol. 2010;6(3):337-44.
41. Roldán T, López A. Intoxicación por acetaminofén en pediatría: Aproximación y manejo. Uni. Méd. 2012;53(1):56-67.
42. Yoon E, Babar A, Choudhary M, Kutner M, Pyrsopoulos N. Acetaminophen-induced hepatotoxicity: A comprehensive update. J Clin Transl Hepatol. 2016;4(2):131-42.
43. Yang X, Salminen WF, Shi Q, Greenhaw J, Gill PS, Bhattacharyya S, et al. Potential of extracellular microRNAs as biomarkers of acetaminophen toxicity in children. Toxicol Appl Pharmacol. 2015;284(2):180-7.
44. Vliegenthart AD, Antoine DJ, Dear JW. Target biomarker profile for the clinical management of paracetamol overdose. Br J Clin Pharmacol. 2015 Sep;80(3):351-62.
45. Bateman DN. Paracetamol poisoning: Beyond the nomogram. Br J Clin Pharmacol. 2015;80(1):45-50.
46. Chomchai S, Lawattanatrakul N, Chomchai C. Acetaminophen Psi Nomogram: A sensitive and specific clinical tool to predict hepatotoxicity secondary to acute acetaminophen overdose. J Med Assoc Thai. 2014;97(2):165-72.
47. Zyoud SH, Awang R, Sulaiman SA, Al-Jabi SW. Association between gastrointestinal manifestations following acetaminophen poisoning and outcome in 291 acetaminophen poisoning patients. Pharmacoepidemiol Drug Saf. 2010;19(5):511-7.
48. Hou YC, Lin JL, Huang WH, Weng CH, Lee SY, Hsu CW, et al. Outcomes of patients with acetaminophen-associated toxic hepatitis at a far east poison center. Springerplus. 2013 Dec 17;2:674.
49. Chen SJ, Lin CS, Hsu CW, Lin CL, Kao CH. Acetaminophen poisoning and risk of acute pancreatitis: A population-based cohort study. Medicine (Baltimore). 2015;94(29):e1195.
50. Heard KJ. Acetylcysteine for acetaminophen poisoning. N Engl J Med. 2008 Jul 17;359(3):285-92.
51. Wong A, Graudins A. N-acetylcysteine regimens for paracetamol overdose: Time for a change? Emerg Med Australas. 2016;28(6):749-51.
52. Zyoud SH, Awang R, Syed Sulaiman SA, Sweileh WM, Al-Jabi SW. Incidence of adverse drug reactions induced by N-acetylcysteine in patients with acetaminophen overdose. Hum Exp Toxicol. 2010;29(3):153-60.
53. Bateman DN, Carroll R, Pettie J, Yamamoto T, Elamin ME, Peart L, et al. Effect of the UK's revised paracetamol poisoning management guidelines on admissions, adverse reactions and costs of treatment. Br J Clin Pharmacol. 2014;78(3):610-8.
54. Owumi SE, Andrus JP, Herzenberg LA, Herzenberg LA. Co-administration of N-acetylcysteine and acetaminophen efficiently blocks acetaminophen toxicity. Drug Dev Res. 2015;76(5):251-8.
55. Bateman DN, Dear JW, Thanacoody HK, Thomas SH, Eddleston M, Sandilands EA, et al. Reduction of adverse effects from intravenous acetylcysteine treatment for paracetamol poisoning: A randomised controlled trial. Lancet. 2014;383(9918):697-704.
56. Mehrpour O, Shadnia S, Sanaei-Zadeh H. Late extensive intravenous administration of N-acetylcysteine can reverse hepatic failure in acetaminophen overdose. Hum Exp Toxicol. 2011;30(1):51-4.
57. Mahmoudi GA, Astaraki P, Mohtashami AZ, Ahadi M. N-acetylcysteine overdose after acetaminophen poisoning. Int Med Case Rep J. 2015;8:65-9.
58. Blackford MG, Felter T, Gothard MD, Reed MD. Assessment of the clinical use of intravenous and oral N-acetylcysteine in the treatment of acute acetaminophen poisoning in children: A retrospective review. Clin Ther. 2011;33(9):1322-30.
59. Srinivasan V, Corwin D, Verceles AC. An accidental overdose of N-acetylcysteine during treatment for acetaminophen toxicity. Clin Toxicol (Phila). 2015;53(5):500.
60. Buckley NA, Dawson AH, Isbister GK. Treatments for paracetamol poisoning. BMJ. 2016;353:i2579.
61. Lucyk SN, Hoffman RS, Nelson LS, Fuentes M, Tavangarian K. Challenges with AST/ALT ratio in acetaminophen poisoning. Clin Toxicol (Phila). 2015;53(7):786.
62. Duffull SB, Isbister GK. Predicting the requirement for N-acetylcysteine in paracetamol poisoning from reported dose. Clin Toxicol (Phila). 2013;51(8):772-6.
63. Abirami A, Nagarani G, Siddhuraju P. Hepatoprotective effect of leaf extracts from Citrus hystrix and C. Maxima against paracetamol induced liver injury in rats. Food Sci Human Well. 2015;4:35-41.
64. Kaplowitz N, Win S, Than TA, Liu ZX, Dara L. Targeting signal transduction pathways which regulate necrosis in acetaminophen hepatotoxicity. J Hepatol. 2015;63(1):5-7.
65. Karadas S, Aslan M, Gonullu H, Kati C, Duran L, Olmez S, et al. Acetaminophen intoxication is associated with decreased serum paraoxonase and arylesterase activities and increased lipid hydroperoxide levels. Hum Exp Toxicol. 2014;33(11):1134-40.
66. Alotaibi SA, Alanazi A, Bakheet SA, Alharbi NO, Nagi MN. Prophylactic and therapeutic potential of acetyl-l-carnitine against acetaminophen-induced hepatotoxicity in mice. J Biochem Mol Toxicol. 2016;30(1):5-11.
67. Carthy ER, Ellis SD. Paracetamol poisoning in the UK: a meeting report from Pharmacology 2013. Expert Rev Clin Pharmacol. 2014;7(2):147-9.

Vol. 59 Núm. 4 (2018)